Pharmacokinetics of Single and Repeat Oral Doses of Trametinib in Chinese Subjects With Solid Tumours
NCT02939846
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Change in strategy
Conditions
Cancer
Interventions
DRUG:
Trametinib
Sponsor
GlaxoSmithKline